Imugene Small Caps Presentation, page-81

  1. 1,368 Posts.
    lightbulb Created with Sketch.  6
    They are using a multi drug combination of Venetoclax which was developed in the 1980s and Retuximab or Ibrutinib which is doubling the survival rates of patients with Lymphocytic leukaemia and mantle cell Lymphoma.No chemo and no side effects.Its not a cure but is halving the death rate of these cancers.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Last
13.5¢
Change
0.000(0.00%)
Mkt cap ! $56.13M
Open High Low Volume
0.0¢ 0.0¢ 0.0¢ 0

Buyers (Bids)

Vol. Price($)
285615 13.0¢
 

Sellers (Offers)

Price($) Vol.
14.0¢ 145434
Last trade - 16.00pm 03/07/2026 (20 minute delay) ?
IMU (ASX) Chart
Day chart unavailable
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.